Arkolith/Insider Trading/CRBP/Form 4

Jenkins John Kenneth

DirectorCorbus Pharmaceuticals Holdings, Inc. (CRBP) · full profile →Form 4 · filed Jun 11, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$38K
Net Open-Market Flow
-$38K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 10, 2026Sell(S)5K$7.91$38K4K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-267671) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML